Thanks for subscribing! Please check your email for further instructions.
Hy-Vee, Inc. announces today that COVID-19 antivirals, Molnupiravir and PAXLOVID, are now available at Hy-Vee Pharmacy locations throughout its eight-state region to help treat eligible patients who have mild-to-moderate cases of COVID-19.
The type of COVID-19 antiviral available varies by pharmacy location.
In order to receive a COVID-19 antiviral, patients must have a prescription from their health care provider. The COVID-19 antivirals are free with most insurances.
According to the FDA’s Emergency Use Authorization (EUA), Molnupiravir and PAXLOVID should be used to treat mild-to-moderate cases of COVID-19 in certain adults (ages 18+) who are at high risk for progression to severe COVID-19, including hospitalization or death. PAXLOVID may also be used to treat mild-to-moderate cases of COVID-19 in eligible pediatric patients ages 12+. It is recommended that patients begin COVID-19 antiviral treatment as soon as possible, and treatment must begin within five days of when symptoms begin.
Both antiviral products may only be used for the treatment of mild-to-moderate COVID-19 in individuals:
Hy-Vee Pharmacy also offers convenient prescription options for patients including drive-thru pharmacy services and free prescription delivery (where available).
In addition to COVID-19 antiviral treatments, all Hy-Vee Pharmacy locations also offer over-the-counter, at-home COVID-19 tests. Under the Biden Administration’s ruling, each individual covered under private insurance or Medicare Part B can currently receive up to eight (8) free at-home COVID-19 tests each month.
Hy-Vee Pharmacy also offers other COVID-19 testing options, available by appointment only at select locations.
Additionally, Hy-Vee Pharmacy offers free COVID-19 vaccines and boosters at all of its pharmacy locations. To learn more or schedule a vaccination, visit www.hy-vee.com/covidvaccine.
***Report Courtesy of Hy-Vee, Inc.***